The Technology Development Board (TDB) under the Department of Science & Technology, Government of India, has extended financial assistance to M/s Ceramat Private Limited, Palghar, Maharashtra, for commercializing advanced 3D-printed patient-specific bone grafts. The project titled 'Calcium Phosphate based Standard and Customized Patient Specific Grafts by 3D Printing via Digital Light Processing Technique and Extrusion-based Equipment' aims to develop indigenous alternatives to imported healthcare products using bioceramic materials.
Ceramat Private Limited specializes in developing and commercializing indigenous technologies in bio-ceramics and advanced ceramics, with a product portfolio that includes hydroxyapatite, beta-tricalcium phosphate, biphasic calcium phosphate, and bioactive glass. These materials serve applications across orthopedics, oral care, cosmetics, and industrial sectors. The company currently manufactures bone grafts and granules through conventional processes but faces manufacturing challenges in producing customized grafts matching individual patient anatomy.
The project addresses this gap by integrating 3D printing technology with indigenously manufactured bioceramic raw materials. Ceramat will develop both standard and customized patient-specific grafts using two complementary approaches: Digital Light Processing (DLP)-based 3D printing and extrusion-based 3D printing. These technologies will enable greater flexibility in developing complex geometries and customised structures suited to specific clinical requirements.
The initiative is aligned with the Government of India's emphasis on Aatmanirbhar Bharat, advanced manufacturing, and indigenous medical technology development. By developing patient-specific graft manufacturing capabilities within the country, the project aims to reduce dependence on imported bioceramic and orthobiological products, strengthen domestic supply chains, and create a platform with potential for global markets. Shri Rajesh Kumar Pathak, Secretary of TDB, emphasized that this development supports India's transition from technology consumer to technology developer in specialized healthcare areas and reduces dependence on imported products while creating possibilities for personalized medical solutions.